Zevra Therapeutics Stock Price on September 13, 2024
| ZVRA Stock | 9.59 0.46 5.04% |
Below is the normalized historical share price chart for Zevra Therapeutics extending back to April 16, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Zevra Therapeutics stands at 9.59, as last reported on the 25th of November, with the highest price reaching 9.64 and the lowest price hitting 9.16 during the day.
If you're considering investing in Zevra Stock, it is important to understand the factors that can impact its price. Zevra Therapeutics appears to be somewhat reliable, given 3 months investment horizon. Zevra Therapeutics shows Sharpe Ratio of 0.15, which attests that the company had a 0.15% return per unit of risk over the last 3 months. By examining Zevra Therapeutics' technical indicators, you can evaluate if the expected return of 0.5% is justified by implied risk. Please utilize Zevra Therapeutics' Downside Deviation of 3.6, mean deviation of 2.51, and Market Risk Adjusted Performance of 0.4627 to validate if our risk estimates are consistent with your expectations.
At present, Zevra Therapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 37.2 M, whereas Common Stock is forecasted to decline to 3,800. . At present, Zevra Therapeutics' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 3.94, whereas Price To Sales Ratio is forecasted to decline to 5.90. Zevra Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of April 2015 | 200 Day MA 6.3581 | 50 Day MA 8.1898 | Beta 1.931 |
Zevra |
Sharpe Ratio = 0.1487
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ZVRA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.38 actual daily | 30 70% of assets are more volatile |
Expected Return
| 0.5 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Zevra Therapeutics is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zevra Therapeutics by adding it to a well-diversified portfolio.
Price Book 7.3328 | Enterprise Value Ebitda (4.24) | Price Sales 20.8913 | Shares Float 49.9 M | Wall Street Target Price 20.1429 |
Related Headline
Trevena Headline on 13th of September 2024
Trevena Stock Price Crosses Below Two Hundred Day Moving Ave... by news.google.com
Trevena Stock Price Crosses Below Two Hundred Day Moving Average of 8.53 MarketBeat
Zevra Therapeutics Valuation on September 13, 2024
It is possible to determine the worth of Zevra Therapeutics on a given historical date. On September 13, 2024 Zevra was worth 7.6 at the beginning of the trading date compared to the closed value of 7.85. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Zevra Therapeutics stock. Still, in general, we apply an absolute valuation method to find Zevra Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Zevra Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Zevra Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 7.40 | 7.84 | 7.35 | 7.59 | 630,095 | |
09/13/2024 | 7.60 | 8.12 | 7.59 | 7.85 | 771,861 |
| 8.00 | 8.18 | 7.77 | 7.78 | 518,647 |
| Backtest Zevra Therapeutics | | | Zevra Therapeutics History | | | Zevra Therapeutics Valuation | Previous | Next |
Zevra Therapeutics Trading Date Momentum on September 13, 2024
| On September 16 2024 Zevra Therapeutics was traded for 7.78 at the closing time. The top price for the day was 8.18 and the lowest listed price was 7.77 . The trading volume for the day was 518.6 K. The trading history from September 16, 2024 was a factor to the next trading day price decrease. The trading date delta against the next closing price was 0.89% . The trading date delta against the current closing price is 3.82% . |
Zevra Therapeutics Fundamentals Correlations and Trends
By evaluating Zevra Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Zevra Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Zevra financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Zevra Therapeutics Stock history
Zevra Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Zevra is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Zevra Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Zevra Therapeutics stock prices may prove useful in developing a viable investing in Zevra Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 35.5 M | 37.2 M | |
| Net Loss | -37.4 M | -39.3 M |
Zevra Therapeutics Quarterly Net Working Capital |
|
Zevra Therapeutics Stock Technical Analysis
Zevra Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Zevra Therapeutics Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Zevra Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Zevra Therapeutics November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Zevra Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zevra Therapeutics shares will generate the highest return on investment. By undertsting and applying Zevra Therapeutics stock market strength indicators, traders can identify Zevra Therapeutics entry and exit signals to maximize returns
Zevra Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Zevra Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Zevra Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Zevra to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1171 | |||
| Jensen Alpha | 0.343 | |||
| Total Risk Alpha | (0.06) | |||
| Sortino Ratio | 0.0963 | |||
| Treynor Ratio | 0.4527 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Zevra Stock analysis
When running Zevra Therapeutics' price analysis, check to measure Zevra Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zevra Therapeutics is operating at the current time. Most of Zevra Therapeutics' value examination focuses on studying past and present price action to predict the probability of Zevra Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zevra Therapeutics' price. Additionally, you may evaluate how the addition of Zevra Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| CEOs Directory Screen CEOs from public companies around the world |